SiRNA designed to target human Htt, a gene involved in Huntington’s disease, which is also a neurodegenerative disorder characterized by cognitive impairment, attenuates striatal neuropathology, and motor deficits in a mouse model of Huntington’s disease (Difiglia et al., 2007). The gene discussed is HTT; the disease is Huntington disease.